Premium
Monoamine systems in depression: towards better understanding of the disorder and improved treatment options
Author(s) -
Baldwin David S.
Publication year - 1998
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/(sici)1099-1077(199806)13:4<293::aid-hup999>3.0.co;2-x
Subject(s) - neuropsychopharmacology , monoaminergic , depression (economics) , monoamine neurotransmitter , psychiatry , psychology , venlafaxine , relevance (law) , medicine , political science , serotonin , anxiety , economics , receptor , antidepressant , macroeconomics , law
At the 10th European College of Neuropsychopharmacology Congress in Vienna, 13–17 September 1997, several presentations addressed the relevance of monoaminergic systems in depression and highlighted possibilities for improving treatment options for depressed patients. © 1998 John Wiley & Sons, Ltd.